List of Excipients in API anagrelide hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing anagrelide hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | ANHYDROUS LACTOSE | |
| Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | CELLULOSE, MICROCRYSTALLINE | |
| Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | CROSPOVIDONE | |
| Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | LACTOSE MONOHYDRATE | |
| Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | MAGNESIUM STEARATE | |
| Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | POVIDONE K30 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing anagrelide hydrochloride
Detailed excipient profiles for anagrelide hydrochloride
Excipient focus: ALUMINUM OXIDE
anagrelide hydrochloride drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
anagrelide hydrochloride drug variants containing ANHYDROUS LACTOSE
anagrelide hydrochloride drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
anagrelide hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
anagrelide hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
anagrelide hydrochloride drug variants containing CROSPOVIDONE
anagrelide hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
anagrelide hydrochloride drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
anagrelide hydrochloride drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
anagrelide hydrochloride drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
anagrelide hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
anagrelide hydrochloride drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
anagrelide hydrochloride drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
anagrelide hydrochloride drug variants containing LACTOSE MONOHYDRATE
anagrelide hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
anagrelide hydrochloride drug variants containing MAGNESIUM STEARATE
anagrelide hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
anagrelide hydrochloride drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
anagrelide hydrochloride drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
anagrelide hydrochloride drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
anagrelide hydrochloride drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
anagrelide hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
| Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
| Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
| >Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
